Tumor biomarkers are usually present in the tumor tissue or serum of cancer patients, containing a variety of molecules, such as DNA, mRNA, transcription factors, enzymes, metabolites, and cell surface receptors (Wu and Qu, 2015) (Figure 1). This evidence concerns the gene CD177 and neoplasm.